Selected publications
“Angiotensin blockade therapy and survival in pancreatic cancer: a population study”
Keith SW, Maio V, Arafat HA, Alcusky M, Karagiannis T, Rabinowitz C, Lavu H, Louis DZ
BMC Cancer. 2022 Feb 7;22(1):150. doi: 10.1186/s12885-022-09200-4. PMID: 35130875; PMCID: PMC8819908
“Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations”
Sarosiek K, Gandhi AV, Saxena S, Kang CY, Chipitsyna GI, Yeo CJ, Arafat HA
J Thyroid Res. 2016;2016:2454989. doi: 10.1155/2016/2454989. Epub 2016 Mar 31. PubMed PMID: 27123358; PubMed Central PMCID: PMC4830736
“Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion, Preliminary Observations”
Sarosiek K, Ankit V. Gandhi AV, Saxena S, Kang CY, Chipitsyna GI, Yeo C, Arafat HA
J. Thyroid Res, 2016, Article ID 2454989
“Angiotensin type 2 receptor: A novel modulator of inflammation in pancreatic ductal adenocarconima through Regulation of NFkB activity”
Gandhi A, Chipitsyna G, Relles D, Yeo CJ, Arafat HA
J. Cancer Tum International, 2017. 5(1) 1-11
“Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation”
Relles D, Chipitsyna GI, Gong Q, Yeo CJ, Arafat HA
Adv Prev Med. 2016;2016:1407840. doi: 10.1155/2016/1407840. Epub 2016 Dec 26. PubMed PMID: 28105374; PubMed Central PMCID: PMC5220391
“Conserved Metabolic Changes in Nondiabetic and Type 2 Diabetic Bariatric Surgery Patients: Global Metabolomic Pilot Study”
Sarosiek K, Pappan KL, Ankit V. Gandhi AV, Saxena S, Christopher Y. Kang CY, McMahon H, Chipitsyna GI, Tichansky DS, Arafat HA
J. Diabetes Res, 2016 (2016), Article ID 3467403
“Osteopotntin (OPN) isoforms in cancer diabetes and obesity, what’s one got to do with the other?”
Sarosiek K, Kang C, AlZoubi M, Chipitsyna G, Saxena S, Gandhi A, Yeo CJ, Arafat HA
J Gastrointest Surg. 2015 Apr;19(4):639-50
“Heme oxygenase-1 gene promoter polymorphism is associated with the development of necrotizing acute pancreatitis”
Gulla A, Evans BJ, Navenot JM, Pundzius J, Barauskas G, Gulbinas A, Dambrauskas Z, Arafat H, Wang ZX
Pancreas. 2014 Nov;43(8):1271-6
“Osteopontin Isoform OPNc: a Potential Marker of Metastasis in Pancreatic Ductal Adenocarcinoma”
Siddiqui A, Jones E, Lazar M+, Salem K, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA
J Gastroenterol Hepatol. 2014 Jun;29(6):1321-7
“Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma”
Kang CY, Wang J, Axell-House D, Soni P, Chu ML, Chipitsyna G, Sarosiek K, Sendecki J, Hyslop T, Al-Zoubi M, Yeo CJ, Arafat HA
J Gastrointest Surg. 2013 Sep 4. [Epub ahead of print] PubMed PMID: 24002763